Literature DB >> 24917211

Surgical resection of severe heterotopic ossification after open reduction and internal fixation of acetabular fractures: a case series of 18 patients.

Xin-Bao Wu1, Ming-Hui Yang1, Shi-Wen Zhu1, Qi-Yong Cao1, Hong-Hua Wu1, Man-Yi Wang1, Derly O Cuellar2, Cyril Mauffrey3.   

Abstract

OBJECTIVE: To evaluate the clinical results of surgical resection of severe heterotopic ossification (HO) after the open reduction and internal fixation (ORIF) of acetabular fractures.
METHODS: A retrospective chart review was performed between October 2005 and November 2010 on patients undergoing severe HO resection following an acetabular fracture ORIF. Our primary outcome was functional status evaluated by the Harris hip score (HSS). HO resection and hip release was performed using a Kocher-Langenbeck approach in all cases, and a combined radiation and indomethacin regimen was used to prevent HO recurrence. Plain radiographs were also used to evaluate the hip joint for arthritic changes and HO recurrence.
RESULTS: A total of 18 patients (17 males and 1 female) were included in our study analysis. The mean patient age was 36.8 (range: 22-54 years old) when HO resection surgery was performed. The mean time interval between acetabular fracture ORIF and HO resection was 9.9 months (range: 3-30 months): it was within 6 months in 7 patients, 6-12 months in 8 patients, and >12 months in 3 patients. The HO was graded as Brooker grade III in 8 patients and grade IV in 10 patients. The mean time interval between HO resection and the latest follow-up was 4.5 years (range: 2.1-7.8 years). The mean Harris hip score (HHS) was 84.5 (range: 38-100), with a clinical outcome rating of excellent in 9 patients, good in 3 patients, fair in 4 patients, and poor in 2 patients (good and excellent rating accounted for 66.7%). The mean hip joint motion arc was 194° (range: 90-260°). Complications included one intraoperative femoral neck fracture, 1 sciatic nerve injury, 2 femoral head avascular necrosis, and 6 mild HO recurrences (33.3%). There was 28.6% recurrence if HO resection was within 6 months and 36.4% if >6 months. There were no cases of severe HO recurrence, wound infections, deep vein thrombosis, or pulmonary embolism.
CONCLUSION: The early surgical resection of severe HO after an acetabular fracture ORIF can provide satisfactory results, however the complication rate is relatively high.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetabular fracture; HO; HO resection; Heterotopic ossification; ORIF; Resection

Mesh:

Year:  2014        PMID: 24917211     DOI: 10.1016/j.injury.2014.05.018

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

Review 1.  Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.

Authors:  Kelly L Wentworth; Umesh Masharani; Edward C Hsiao
Journal:  Br J Clin Pharmacol       Date:  2019-01-06       Impact factor: 4.335

2.  Results from the surgical resection of severe heterotopic ossification of the hip: a case series of 26 patients.

Authors:  George A Macheras; Panagiotis Lepetsos; Andreas Leonidou; Panagiotis P Anastasopoulos; Spyridon P Galanakos; Eleftherios Tsiridis
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-06

3.  Rescue of ankylosing hip following open reduction and internal fixation of acetabular fracture by surgical resection of heterotopic ossification: A case report.

Authors:  Kazumichi Kitayama; Yohei Kawakami; Tomoaki Fukui; Keisuke Oe; Ryosuke Kuroda; Takahiro Niikura
Journal:  Int J Surg Case Rep       Date:  2018-10-19

4.  Ankylosing Neurogenic Myositis Ossificans of the Hip: A Case Series and Review of Literature.

Authors:  Byung-Ho Yoon; In Keun Park; Yerl-Bo Sung
Journal:  Hip Pelvis       Date:  2018-06-04

5.  A Rare Case of Extremely Severe Heterotopic Ossification after Primary Total Hip Arthroplasty due to Persistent Mild Periprosthetic Joint Infection.

Authors:  Yutaka Kinoshita; Shunji Nakano; Shinji Yoshioka; Masaru Nakamura; Tomohiro Goto; Daisuke Hamada; Koichi Sairyo
Journal:  Case Rep Orthop       Date:  2021-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.